PharmaShots | Incisive News in 3 Shots

Subscribe Now

P-lV Study

Novartis Reports Results of Aimovig (erenumab) in P-lV Study for Episodic and Chronic Migraine

Novartis Reports Results of Aimovig (erenumab) in P-lV Study for Episodic and Chronic Migraine

November 2, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us